NCT05003713View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Healthy
Interventions
DRUG

CORT125236

CORT125236 Lipid Capsule Formulation 10-60 mg for oral administration

DRUG

Placebo matching CORT125236

Placebo matching CORT125236 Lipid Capsule Formulation 10-60 mg for oral administration

DRUG

Prednisone

Prednisone tablet 25 mg (20 mg + 5 mg tablets) for oral administration

Trial Locations (1)

NG11 6JS

Site 01, Ruddington

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY